TITLE

Autoimmune Pancreatitis: Differences Between the Focal and Diffuse Forms in 87 Patients

AUTHOR(S)
Frulloni, Luca; Scattolini, Chiara; Falconi, Massimo; Zamboni, Giuseppe; Capelli, Paola; Manfredi, Riccardo; Graziani, Rossella; D'Onofrio, Mirko; Katsotourchi, Anna Maria; Amodio, Antonio; Benini, Luigi; Vantini, Italo
PUB. DATE
September 2009
SOURCE
American Journal of Gastroenterology;Sep2009, Vol. 104 Issue 9, p2288
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES:Autoimmune pancreatitis (AIP) is a particular type of chronic pancreatitis that can be classified into diffuse and focal forms. The aim of this study was to analyze clinical and instrumental features of patients suffering from the diffuse and focal forms of AIP.METHODS:AIP patients diagnosed between 1995–2008 were studied.RESULTS:A total of 87 AIP patients (54 male and 33 female patients, mean age 43.4±15.3 years) were studied. Focal-type AIP was diagnosed in 63% and diffuse-type in 37%. Association with autoimmune diseases was observed in 53% of cases, the most common being ulcerative colitis (30%). Serum levels of IgG4 exceeded the upper normal limits (135 mg/dl) in 66% of focal AIP and in 27% of diffuse AIP (P=0.006). All patients responded to steroids. At recurrence non-steroid immunosuppressive drugs were successfully used in six patients. Recurrences were observed in 25% of cases, and were more frequent in focal AIP (33%) than in diffuse AIP (12%) (P=0.043), in smokers than in non-smokers (41% vs. 15%; P=0.011), and in patients with pathological serum levels of IgG4 compared to those with normal serum levels (50% vs. 12%; P=0.009). In all, 23% of the patients underwent pancreatic resections. Among patients with focal AIP, recurrences were observed in 30% of operated and in 34% of not operated patients.CONCLUSIONS:Focal-type and diffuse-type AIP differ as regards clinical symptoms and signs. Recurrences occur more frequently in focal AIP than in diffuse AIP. The use of non-steroid immunosuppressants may be a therapeutic option in relapsing AIP.
ACCESSION #
44012436

 

Related Articles

  • Evaluation and Management of Autoimmune Pancreatitis: Experience at a Large US Center. Raina, Amit; Yadav, Dhiraj; Krasinskas, Alyssa M.; McGrath, Kevin M.; Khalid, Asif; Sanders, Michael; Whitcomb, David C.; Slivka, Adam // American Journal of Gastroenterology;Sep2009, Vol. 104 Issue 9, p2295 

    OBJECTIVES:Autoimmune pancreatitis (AIP) is increasingly recognized as a form of chronic pancreatitis. Systematic evaluation and management of AIP in the United States is reported only from one center. Our aim was to review the evaluation and management of AIP at a large tertiary...

  • Autoimmune Pancreatitis: Pathologic Subtypes and Their Implications for Its Diagnosis. Sugumar, Aravind; Klöppel, Günter; Chari, Suresh T. // American Journal of Gastroenterology;Sep2009, Vol. 104 Issue 9, p2308 

    Autoimmune pancreatitis (AIP) is a rare but treatable form of pancreatic disease that is being increasingly recognized worldwide. The diagnosis of AIP remains a clinical challenge and the difficulty is compounded by the fact that there are no internationally agreed on diagnostic criteria for...

  • Alternatives to steroids?! Beneficial effects of immunosuppressant drugs in autoimmune pancreatitis. Seleznik, Gitta; Graf, Rolf // Gut;Mar2014, Vol. 63 Issue 3, p376 

    In this article, the author comments on the findings of a study titled "Autoimmune pancreatitis in MRL/Mp mice is a T-cell mediated disease responsive to cyclosporine A and rapamycin treatment" by T. Schwaiger and colleagues, published in the periodical in a 2014 issue. Topics discussed include...

  • The latest approaches to pancreatic disease. Abbruzzese, James L.; Lowy, Andrew M.; Pleskow, Douglas; Pennachio, Dorothy L. // Patient Care for the Nurse Practitioner;Sep2001, Vol. 4 Issue 9, p41 

    Provides information on acute pancreatitis (AP), a self-limiting acute inflammatory process that may involve peripancreatic tissues and remote organ systems. Conditions associated with AP; Signs and symptoms of AP; Techniques in the diagnosis of AP; Therapeutic management approaches.

  • Recurrent Attacks of Autoimmune Pancreatitis Result in Pancreatic Stone Formation. Takayama, Mari; Hamano, Hideaki; Ochi, Yasuhide; Saegusa, Hisanobu; Komatsu, Kenichi; Muraki, Takashi; Arakura, Norikazu; Imai, Yasuharu; Hasebe, Osamu; Kawa, Shigeyuki // American Journal of Gastroenterology;May2004, Vol. 99 Issue 5, p932 

    OBJECTIVES: Autoimmune pancreatitis has been characterized by irregular narrowing of the main pancreatic duct and sonolucent swelling of the parenchyma, both of which are due to lymphoplasmacytic inflammation at the active stage of the disease, and by the absence of pancreatic stone formation....

  • Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Kamisawa, Terumi; Egawa, Naoto; Nakajima, Hitoshi; Tsuruta, Kouji; Okamoto, Atsutake; Kamata, Noriko // American Journal of Gastroenterology;Dec2003, Vol. 98 Issue 12, p2694 

    OBJECTIVES: Autoimmune pancreatitis (AIP) is a newly described entity with characteristic clinical, histologic, and morphologic changes, in which autoimmune mechanisms are involved in pathogenesis. However, difficulties can arise in the differentiation of AlP from pancreatic carcinoma. The aims...

  • Duodenal perforation due to a kink in a nasojejunal feeding tube in a patient with severe acute pancreatitis: a case report. Zhihui Tong; Weiqin Li; Xinying Wang; Xianghong Ye; Ning Li; Jieshou Li // Journal of Medical Case Reports;2010, Vol. 4 Issue 1, p1 

    Introduction: Nasojejunal feeding tube placement can be achieved by fluoroscopic or endoscopic techniques. Significant complications due to nasojejunal feeding tube placement, such as hydrothorax, duodenal perforation and retroperitoneal emphysema, are very rare. We present a case of massive...

  • Autoimmune pancreatitis can develop into chronic pancreatitis. Masahiro Maruyama; Takayuki Watanabe; Keita Kanai; Takaya Oguchi; Jumpei Asano; Tetsuya Ito; Yayoi Ozaki; Takashi Muraki; Hideaki Hamano; Norikazu Arakura; Shigeyuki Kawa // Orphanet Journal of Rare Diseases;2014, Vol. 9 Issue 1, p1 

    Autoimmune pancreatitis (AIP) has been recognized as a distinct type of pancreatitis that is possibly caused by autoimmune mechanisms. AIP is characterized by high serum IgG4 and IgG4-positive plasma cell infiltration in affected pancreatic tissue. Acute phase AIP responds favorably to...

  • Autoimmune pancreatitis in Japan: overview and perspective. Shimosegawa, Tooru; Kanno, Atsushi // Journal of Gastroenterology;2009, Vol. 44 Issue 6, p503 

    Since the rediscovery and definition of autoimmune pancreatitis (AIP) by Yoshida et al. in 1995, the disease has been attracting attention because of its unique clinical features and practical issues. This disease shows very impressive imaging findings, serological changes, and characteristic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics